PROM1 and head and neck squamous cell carcinoma: Additionally, down-regulation of CD133 or inhibition of CD133 induced Src activation lessens stemness properties and tumorigenicity of HNSCCs both in vitro and in vivo. Ultimately, we demonstrate the significance of CD133/Src signaling on EMT process in HNSCC.